DEAN PETKANAS Insider Profile
4 Followers
DEAN PETKANAS, former CEO, Director, Ten Percent Owner at Neuropathix, holds 23.15M shares in Neuropathix (Ticker: NPTX).
DEAN PETKANAS's Trading History
You May Also Like
DEAN PETKANAS insider profile FAQ
What stocks does DEAN PETKANAS hold?
DEAN PETKANAS holds: NPTX stocks.
What was DEAN PETKANAS’s latest transaction?
DEAN PETKANAS’s latest transaction was an Uninformative Sell of $4.00K.
What was DEAN PETKANAS's most profitable transaction?
DEAN PETKANAS’s most profitable transaction was an Informative Sell of NPTX stock on December 3, 2019. The return on the trade was -542.80%.
What is DEAN PETKANAS's role in Neuropathix?
DEAN PETKANAS's role in Neuropathix is CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
